Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome

Background: Acute respiratory distress syndrome (ARDS) is a major cause of mortality in intensive care patients and lacks effective treatments. A previous randomised controlled Phase II trial suggested that an intravenous (i.v.) infusion of salbutamol may be beneficial, as it reduced extravascular l...

ver descrição completa

Detalhes bibliográficos

Principais autores:	S Gates, GD Perkins, SE Lamb, C Kelly, DR Thickett, JD Young, DF McAuley, C Snaith, C McCabe, CT Hulme, F Gao Smith
Formato:	Artigo
Idioma:	Inglês
Publicado em:	NIHR Journals Library 2013-09-01
coleção:	Health Technology Assessment
Assuntos:	randomised controlled trial cost-effectiveness clinical effectiveness acute respiratory distress syndrome salbutamol beta agonist lung injury trial
Acesso em linha:	https://doi.org/10.3310/hta17380
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!